$ALMS

Pangali Sanam sold $140K of ALMS

Pangali Sanam (Chief Legal Officer) sold 5,000 shares of ALUMIS INC. (ALMS) at $28.00 ($0.14M total) on 2026-07-06.

Original reporting
SEC EDGAR · Pangali Sanam
Published Jul 8, 2026, 8:40 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 8, 2026, 8:42 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ALMS
Neutral
high confidence
Mentioned
$ALMS
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ALMSNeutralLow
01

Why it matters

The disclosure updates the record of insider activity. It may influence short-term sentiment, but it does not provide new operational or financial information about ALMS.

02

Market read

Traders may monitor insider activity, but this specific sale is unlikely to change valuation without accompanying company fundamentals.

03

What to watch

No 10b5-1 plan is stated, but the filing does not provide intent, liquidity needs, or whether other planned sales occurred.

Relevance 4/10Novelty 3/10Timing: Filed 2026-07-08 after-hours; reflects sale executed 2026-07-06.

Background

This is an SEC Form 4 insider transaction for ALUMIS INC. (ALMS) by its Chief Legal Officer.

Company-level read

Ticker impact

$ALMSNeutralHigh confidence
Context

SEC Form 4 shows ALMS Chief Legal Officer Pangali Sanam sold 5,000 shares at $28.00 on 2026-07-06 for $140,000.

Expected impact

Low likelihood of sustained price impact; any reaction is likely short-lived.

Evidence & confidence

The filing is a Form 4 insider transaction, not an earnings, guidance, or corporate event. The disclosed sale size is modest and does not indicate a company-specific catalyst.

Market effects

No clear sector read-across from a single insider sale.

None indicated.

None indicated.

Counterpoint

Insider sales can be tax or diversification-driven and may not reflect negative views, especially when holdings remain substantial.

Key entities

  • ALUMIS INC.

    Company whose insider transaction is disclosed on Form 4.

  • Pangali Sanam

    Chief Legal Officer who sold 5,000 shares at $28.00.

Related articles

$ALMSMedAI 9/10

Analyst Sentiment On Alumis (ALMS) Remains Strong Following Q1 Results And Envudeucitinib Pipeline Advancements

Alumis Inc. (ALMS) shares drew three analyst price-target raises after its Q1 2026 results and progress on envudeucitinib. Chardan lifted its target to $40 from $38 (Buy), Wells Fargo to $51 from $49 (Overweight), and Guggenheim to $34 from $32 (Buy). The company reported $569.5M cash and narrowed net loss to $93.1M; envudeucitinib Week 24 PASI 90/100 results were also cited.